Semi-Annual Statement Of Income And Retained Earnings

KYORIN Pharmaceutical Co., Ltd. - Filing #7725436

Concept 2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
8,822,000,000 JPY
8,260,000,000 JPY
187,000,000 JPY
8,447,000,000 JPY
375,000,000 JPY
4,624,000,000 JPY
4,712,000,000 JPY
10,104,000,000 JPY
10,106,000,000 JPY
-1,000,000 JPY
10,413,000,000 JPY
308,000,000 JPY
Non-operating income
Non-operating income
640,000,000 JPY
109,000,000 JPY
108,000,000 JPY
510,000,000 JPY
Non-operating expenses
Non-operating expenses
118,000,000 JPY
49,000,000 JPY
Ordinary profit (loss)
9,345,000,000 JPY
4,734,000,000 JPY
4,821,000,000 JPY
10,874,000,000 JPY
Extraordinary income
Extraordinary income
627,000,000 JPY
710,000,000 JPY
JPY
48,000,000 JPY
Extraordinary losses
Extraordinary losses
910,000,000 JPY
429,000,000 JPY
0 JPY
1,205,000,000 JPY
Profit (loss) before income taxes
9,061,000,000 JPY
5,015,000,000 JPY
4,821,000,000 JPY
9,716,000,000 JPY
Income taxes - current
2,759,000,000 JPY
95,000,000 JPY
120,000,000 JPY
1,597,000,000 JPY
Income taxes - deferred
-272,000,000 JPY
255,000,000 JPY
-253,000,000 JPY
814,000,000 JPY
Profit (loss)
4,663,000,000 JPY
6,574,000,000 JPY
4,663,000,000 JPY
4,663,000,000 JPY
4,663,000,000 JPY
4,954,000,000 JPY
7,305,000,000 JPY
4,954,000,000 JPY
4,954,000,000 JPY
4,954,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.